Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Amgen inc. crawled date : 2022 - 03 - 16 save search
Global Lupus Therapeutic Market to Surpass US$ 5,408.1 Million by 2030, Says Coherent Market Insights
Published: 2022-03-16 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -0.46%
H: 3.49%
C: 3.49%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
UCBJY | $64.93 -4.38% 6.2K
|
Manufacturing
|
| O: 1.41%
H: 2.33%
C: 0.04%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 2.07%
H: 1.62%
C: 1.56%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.26%
H: 0.31%
C: -0.39%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
AUPH | $5.085 0.69% 0.59% 920K
|
Health Technology
|
| O: 0.95%
H: 6.23%
C: 5.19%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -0.37%
lupus market
Hematological Malignancies Emerging Therapeutics - A Global Industry Assessment with Insights & Projections by Therapeutic Type, Potential Pipeline Products, Indication, and Region, 2021-2031
Published: 2022-03-16 (Crawled : 14:30) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -0.46%
H: 3.49%
C: 3.49%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 2.07%
H: 1.62%
C: 1.56%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 1.23%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.26%
H: 0.31%
C: -0.39%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.4%
H: 0.2%
C: -0.29%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: -1.19%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -0.37%
ema therapeutics potential
KayoThera, Inc. Raises $8 Million in Series A Financing Led by Accelerator Life Science Partners to Develop Novel Cancer Immunotherapeutics
Published: 2022-03-16 (Crawled : 14:00) - biospace.com/
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -0.37%
therapeutics cel cancer life science
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.